WeVote
Log In

Bill

Bill

HD 77

An Act establishing a transferable pediatric cancer research tax credit

194th Legislature (2025-2026) Introduced by Marcus Vaughn

Massachusetts bill creates transferable tax credits for pediatric cancer research donations, incentivizing private funding while reducing state tax revenue.

0
WeVote Research Nonpartisan
Bill Summary · HD 77

Legislative bill overview

HD 77 establishes a transferable tax credit for Massachusetts businesses and individuals that fund pediatric cancer research. The credit allows taxpayers to reduce their tax liability based on qualifying contributions to approved research institutions. Because the credit is transferable, those who cannot fully utilize it can sell it to other taxpayers.

Why is this important

Pediatric cancer research receives less private funding than adult cancer research despite affecting thousands of children annually. By creating a financial incentive through tax credits, the bill aims to increase private capital flowing to this underfunded research area while also reducing the state's tax revenue. The transferability feature makes the credit valuable to a broader range of entities, potentially increasing participation.

Potential points of contention

  • Fiscal impact: The state foregoes tax revenue equal to the credits issued, creating costs that must be absorbed through reduced services, higher taxes elsewhere, or deficit spending
  • Who benefits: Transferable credits primarily benefit wealthy individuals and corporations with high tax liabilities who can afford large research donations; smaller donors gain less value
  • Accountability: Questions arise about which research institutions qualify, how effectiveness is measured, and whether the credit actually increases research funding or simply subsidizes donations that would occur anyway

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.